{"id":"comparator-oxycodone-and-acetaminophen","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Constipation"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Drowsiness"},{"rate":null,"effect":"Vomiting"},{"rate":null,"effect":"Pruritus"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Oxycodone binds to mu-opioid receptors in the central nervous system to modulate pain perception and transmission. Acetaminophen works through distinct mechanisms including inhibition of prostaglandin synthesis and modulation of descending pain pathways. The combination provides synergistic analgesia for moderate to moderately severe pain management.","oneSentence":"This is a fixed-dose combination of oxycodone (a mu-opioid receptor agonist) and acetaminophen (a non-opioid analgesic) that provides pain relief through dual mechanisms.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:43:29.218Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Moderate to moderately severe acute or chronic pain"}]},"trialDetails":[{"nctId":"NCT05488847","phase":"PHASE4","title":"Opioid-Free Pain Protocol After Shoulder Arthroplasty","status":"ACTIVE_NOT_RECRUITING","sponsor":"Henry Ford Health System","startDate":"2022-06-25","conditions":"Shoulder Arthropathy, Shoulder Pain","enrollment":83},{"nctId":"NCT05231460","phase":"PHASE4","title":"Pain Management Study","status":"ENROLLING_BY_INVITATION","sponsor":"University of Arizona","startDate":"2022-02-18","conditions":"Pain, Postoperative","enrollment":244},{"nctId":"NCT03789318","phase":"PHASE2","title":"Study in Subjects Undergoing Complete Abdominoplasty","status":"COMPLETED","sponsor":"Concentric Analgesics","startDate":"2018-12-03","conditions":"Postsurgical Pain","enrollment":54},{"nctId":"NCT03319277","phase":"NA","title":"A Randomized-controlled Trial of Post-operative Opiate Quantities After Urogynecologic Surgery","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2017-10-13","conditions":"Postoperative Pain, Opioid Use","enrollment":118},{"nctId":"NCT01270659","phase":"PHASE3","title":"Safety and Efficacy Study of Fentanyl Buccal Tablet Use in the Emergency Department for Isolated Extremity Injury","status":"COMPLETED","sponsor":"University of Oklahoma","startDate":"2011-05","conditions":"Pain","enrollment":60},{"nctId":"NCT02462811","phase":"PHASE3","title":"A Double-Blind, Randomized, Active- and Placebo-Controlled, Multiple-Dose Multi-Center Phase 3 Study of the Safety and Efficacy of CL-108 in the Treatment of Moderate to Severe Acute Pain and Opioid-Induced Nausea and Vomiting (OINV)","status":"COMPLETED","sponsor":"Joseph Hazelton","startDate":"2014-09","conditions":"Pain, Nausea, Vomiting","enrollment":552},{"nctId":"NCT00092326","phase":"PHASE3","title":"A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-183)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2002-06","conditions":"Postoperative Pain","enrollment":269},{"nctId":"NCT00092313","phase":"PHASE3","title":"A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-182)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2002-06","conditions":"Postoperative Pain","enrollment":271},{"nctId":"NCT00385684","phase":"PHASE4","title":"Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2007-10","conditions":"Alzheimer Disease, Dementia, Dementia, Vascular","enrollment":11}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":58,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Comparator: oxycodone and acetaminophen","genericName":"Comparator: oxycodone and acetaminophen","companyName":"Merck Sharp & Dohme LLC","companyId":"merck","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a fixed-dose combination of oxycodone (a mu-opioid receptor agonist) and acetaminophen (a non-opioid analgesic) that provides pain relief through dual mechanisms. Used for Moderate to moderately severe acute or chronic pain.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}